Yingjue Zhang

Suita, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer.

miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer.

Journal: International journal of molecular sciences

Published: March 13, 2026

Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights.

Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights.

Journal: Cancers

Published: February 26, 2026

The miR-29b Byproduct MIRTX Shows Superior Anti-tumor Activity, Compared to miR-29b-3p, in Pancreatic Cancer Cells.

The miR-29b Byproduct MIRTX Shows Superior Anti-tumor Activity, Compared to miR-29b-3p, in Pancreatic Cancer Cells.

Journal: Anticancer research

Published: November 08, 2025

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.

Journal: Frontiers in genetics

Published: May 06, 2023

Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer.

Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer.

Journal: Frontiers in immunology

Published: January 12, 2023

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.

Journal: Frontiers in genetics

Published: September 07, 2022

A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.

A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.

Journal: Aging

Published: April 26, 2022

Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer.

Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer.

Journal: Frontiers in cell and developmental biology

Published: April 06, 2022

Tumor microenvironment-related multigene prognostic prediction model for breast cancer.

Tumor microenvironment-related multigene prognostic prediction model for breast cancer.

Journal: Aging

Published: October 28, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026